J
Jeisys Medical Inc
KOSDAQ:287410
Jeisys Medical Inc
KOSDAQ:287410
Price:
12 900
KRW
0.16%
Market Closed
Market Cap:
976.4B
KRW
Income Statement
Earnings Waterfall
Jeisys Medical Inc
Jeisys Medical Inc
|
Revenue
|
167.8B
KRW
|
|
Cost of Revenue
|
-50.7B
KRW
|
|
Gross Profit
|
117.1B
KRW
|
|
Operating Expenses
|
-78.9B
KRW
|
|
Operating Income
|
38.2B
KRW
|
|
Other Expenses
|
-10.2B
KRW
|
|
Net Income
|
28B
KRW
|
Income Statement
Jeisys Medical Inc
Jeisys Medical Inc
Currency: KRW
Millions
TTM
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
18 284
N/A
|
38 301
+109%
|
58 705
+53%
|
81 296
+38%
|
88 147
+8%
|
98 901
+12%
|
107 139
+8%
|
116 550
+9%
|
120 320
+3%
|
124 711
+4%
|
135 176
+8%
|
143 030
+6%
|
157 881
+10%
|
167 823
+6%
|
|
| Gross Profit | ||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5 230)
|
(11 536)
|
(17 562)
|
(24 649)
|
(26 917)
|
(30 667)
|
(33 800)
|
(36 975)
|
(38 893)
|
(39 353)
|
(42 204)
|
(44 060)
|
(47 636)
|
(50 713)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
13 054
N/A
|
26 764
+105%
|
41 143
+54%
|
56 647
+38%
|
61 230
+8%
|
68 234
+11%
|
73 338
+7%
|
79 575
+9%
|
81 427
+2%
|
85 358
+5%
|
92 972
+9%
|
98 970
+6%
|
110 245
+11%
|
117 110
+6%
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(66)
|
(60)
|
(50)
|
(53)
|
(54)
|
(61)
|
(56)
|
(108)
|
(102)
|
(8 420)
|
(15 969)
|
(24 088)
|
(33 042)
|
(33 650)
|
(37 843)
|
(41 428)
|
(45 540)
|
(48 327)
|
(51 569)
|
(56 676)
|
(62 656)
|
(72 685)
|
(78 948)
|
|
| Selling, General & Administrative |
(66)
|
(60)
|
(50)
|
(53)
|
(54)
|
(61)
|
(56)
|
(108)
|
(102)
|
(7 506)
|
(14 034)
|
(21 152)
|
(28 481)
|
(28 897)
|
(32 617)
|
(36 197)
|
(40 393)
|
(43 467)
|
(46 566)
|
(51 101)
|
(56 460)
|
(66 080)
|
(71 944)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(394)
|
(927)
|
(1 372)
|
(2 193)
|
(2 298)
|
(2 665)
|
(2 726)
|
(2 507)
|
(2 796)
|
(2 663)
|
(2 849)
|
(2 748)
|
(3 049)
|
(3 392)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(520)
|
(1 008)
|
(1 574)
|
(2 143)
|
(2 241)
|
(2 347)
|
(2 277)
|
(2 585)
|
(2 009)
|
(2 288)
|
(2 674)
|
(3 448)
|
(3 556)
|
(3 612)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
(225)
|
(214)
|
(214)
|
(228)
|
(55)
|
(55)
|
(52)
|
(52)
|
0
|
0
|
0
|
|
| Operating Income |
(66)
N/A
|
(60)
+9%
|
(50)
+17%
|
(53)
-5%
|
(54)
-2%
|
(61)
-13%
|
(56)
+8%
|
(108)
-95%
|
(102)
+5%
|
4 634
N/A
|
10 796
+133%
|
17 055
+58%
|
23 604
+38%
|
27 580
+17%
|
30 391
+10%
|
31 910
+5%
|
34 035
+7%
|
33 100
-3%
|
33 789
+2%
|
36 296
+7%
|
36 314
+0%
|
37 560
+3%
|
38 162
+2%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
61
|
92
|
102
|
101
|
100
|
103
|
97
|
69
|
74
|
28
|
(169)
|
213
|
147
|
27
|
713
|
1 743
|
114
|
1 039
|
(1 086)
|
(2 560)
|
(755)
|
(1 648)
|
235
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
(18)
|
(0)
|
(65)
|
(42)
|
(64)
|
(70)
|
(5)
|
(15)
|
(25)
|
(26)
|
(32)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10 620)
|
(10 684)
|
(10 854)
|
(10 641)
|
3
|
32
|
178
|
(199)
|
(149)
|
(125)
|
(131)
|
(35)
|
(76)
|
(70)
|
|
| Pre-Tax Income |
(5)
N/A
|
31
N/A
|
52
+64%
|
48
-6%
|
47
-3%
|
42
-10%
|
41
-3%
|
(39)
N/A
|
(28)
+27%
|
(5 959)
-20 875%
|
(58)
+99%
|
6 401
N/A
|
13 093
+105%
|
27 610
+111%
|
31 068
+13%
|
33 788
+9%
|
33 886
+0%
|
33 921
+0%
|
32 573
-4%
|
33 591
+3%
|
35 498
+6%
|
35 810
+1%
|
38 293
+7%
|
|
| Net Income | ||||||||||||||||||||||||
| Tax Provision |
1
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(3)
|
9
|
7
|
(370)
|
(649)
|
(721)
|
667
|
(842)
|
(2 573)
|
(4 440)
|
(6 874)
|
(6 740)
|
(6 503)
|
(6 650)
|
(10 390)
|
(10 355)
|
(9 847)
|
|
| Income from Continuing Operations |
(4)
|
24
|
44
|
41
|
40
|
36
|
38
|
(30)
|
(21)
|
(6 329)
|
(707)
|
5 679
|
13 761
|
26 769
|
28 495
|
29 349
|
27 012
|
27 181
|
26 070
|
26 941
|
25 108
|
25 456
|
28 446
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
99
|
137
|
184
|
163
|
117
|
79
|
(13)
|
(145)
|
(307)
|
(410)
|
(476)
|
|
| Net Income (Common) |
(4)
N/A
|
24
N/A
|
44
+81%
|
41
-7%
|
40
-4%
|
36
-9%
|
38
+5%
|
(30)
N/A
|
(21)
+29%
|
(6 329)
-29 753%
|
(707)
+89%
|
5 537
N/A
|
13 592
+145%
|
26 445
+95%
|
28 218
+7%
|
29 243
+4%
|
27 130
-7%
|
27 260
+0%
|
26 057
-4%
|
26 795
+3%
|
24 800
-7%
|
25 045
+1%
|
27 969
+12%
|
|
| EPS (Diluted) |
-1.26
N/A
|
5.77
N/A
|
10.45
+81%
|
9.74
-7%
|
9.35
-4%
|
8.52
-9%
|
8.96
+5%
|
-7.04
N/A
|
-5.01
+29%
|
-90.71
-1 711%
|
-9.09
+90%
|
78.38
N/A
|
176.51
+125%
|
342.71
+94%
|
395.76
+15%
|
410.14
+4%
|
353.8
-14%
|
353.74
0%
|
335.66
-5%
|
350.69
+4%
|
320.44
-9%
|
325.3
+2%
|
363.02
+12%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
